(Alliance News) - Trellus Health PLC on Friday announced the launch of its direct-to-consumer offering for people living with irritable bowel syndrome.

The New York-based digital health platform provider said that the product, which it did not name, delivers personalised behavioural, emotional and nutritional support remotely via digital solutions, and provides access to a resilience team via telehealth. It also said the offering would help to drive awareness and demand for the business.

Further, Trellus has expanded one of its existing agreements with the Mount Sinai Health System, under which the Trellus Resilience Training and Self-Management Solution is being made available as a wellness benefit to members of a large New York State labour union which provides health services and benefits to its members through the hospital.

Under the expanded contract, the Trellus method will now be available to people living with IBS as well as to patients with inflammatory bowel disease.

"I am delighted to be in a position to launch the Trellus method for IBS program, through both our D2C offering and by expanding one of our contracts with Mount Sinai. Trellus now offers a comprehensive gastroenterology solution for both IBS and IBD, and this represents the culmination of a lot of hard work by the team," said Chief Executive Officer Marla Dubinsky.

"IBS affects around 30 million people in the US, and often has a significant impact on a person's quality of life. We look forward to working with patients and partners to further evaluate how the Trellus method can empower those suffering with IBD, and now also IBS, to achieve better health outcomes and increased quality of life, with reduced healthcare costs."

Trellus shares were trading 9.1% higher at 8.18 pence each in London on Friday afternoon.

By Holly Beveridge; Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.